These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9355824)

  • 1. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants.
    Yamagami S; Kawashima H; Tsuru T; Yamagami H; Kayagaki N; Yagita H; Okumura K; Gregerson DS
    Transplantation; 1997 Oct; 64(8):1107-11. PubMed ID: 9355824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice.
    Osawa H; Maruyama K; Streilein JW
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1908-15. PubMed ID: 15161857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis.
    Hegde S; Beauregard C; Mayhew E; Niederkorn JY
    Transplantation; 2005 Jan; 79(1):23-31. PubMed ID: 15714165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
    Stuart PM; Griffith TS; Usui N; Pepose J; Yu X; Ferguson TA
    J Clin Invest; 1997 Feb; 99(3):396-402. PubMed ID: 9022072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
    Shi W; Chen M; Xie L
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Fas ligand as an effector molecule in corneal graft rejection.
    Stuart PM; Yin X; Plambeck S; Pan F; Ferguson TA
    Eur J Immunol; 2005 Sep; 35(9):2591-7. PubMed ID: 16114107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
    Hori J; Joyce NC; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule.
    Hori J; Joyce N; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):443-52. PubMed ID: 10670474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.
    Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M
    Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cleavable mutant Fas ligand transfection of donor cornea abrogates ocular immune privilege.
    Sano Y; Yamada J; Ishino Y; Adachi W; Kawasaki S; Suzuki T; Kinoshita S; Okuyama T; Azuma N
    Exp Eye Res; 2002 Oct; 75(4):475-83. PubMed ID: 12387794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated rejection of Fas ligand-expressing heart grafts.
    Takeuchi T; Ueki T; Nishimatsu H; Kajiwara T; Ishida T; Jishage K; Ueda O; Suzuki H; Li B; Moriyama N; Kitamura T
    J Immunol; 1999 Jan; 162(1):518-22. PubMed ID: 9886428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FasL-Fas interactions regulate neovascularization in the cornea.
    Stuart PM; Pan F; Plambeck S; Ferguson TA
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):93-8. PubMed ID: 12506060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice.
    Uchiyama H; Kishihara K; Minagawa R; Hashimoto K; Sugimachi K; Nomoto K
    Immunology; 2002 Apr; 105(4):450-7. PubMed ID: 11985665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal graft rejection occurs despite Fas ligand expression and apoptosis of infiltrating cells.
    Williams KA; Standfield SD; Smith JR; Coster DJ
    Br J Ophthalmol; 2005 May; 89(5):632-8. PubMed ID: 15834099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection.
    Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS
    Transplantation; 1999 May; 67(10):1295-300. PubMed ID: 10360580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege.
    Gregory MS; Repp AC; Holhbaum AM; Saff RR; Marshak-Rothstein A; Ksander BR
    J Immunol; 2002 Sep; 169(5):2727-35. PubMed ID: 12193747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CTLA4-FasL protein for the prevention of immune rejection in mouse corneal transplantation].
    Chen M; Shi WY; Wang FH; Xie LX
    Zhonghua Yan Ke Za Zhi; 2008 Jan; 44(1):56-60. PubMed ID: 18510245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of CD8+ and CD8- T lymphocytes in corneal allograft rejection in 'high-risk' hosts.
    Niederkorn JY; Stevens C; Mellon J; Mayhew E
    Am J Transplant; 2006 Apr; 6(4):705-13. PubMed ID: 16539627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Fas ligand in ocular tissue.
    Sano Y; Sotozono C
    Cornea; 2002 Mar; 21(2 Suppl 1):S30-2. PubMed ID: 11995807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.